Renascience (TSE:4889) ROCE % : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Renascience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Renascience's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.00%.

Renascience ROCE % Historical Data

The historical data trend for Renascience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience ROCE % Chart

Renascience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

-18.28

-9.05

-14.41

-14.60

-12.20

Renascience Quarterly Data
	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial										0.45	-17.88	-24.57	-6.24	-

Renascience ROCE % Calculation

Renascience's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-252.336	/	( ( (2274.818 - 100.158)	+	(2088.833 - 126.008) )	/ 2 )
	=	-252.336	/	( (2174.66	+	1962.825)	/ 2 )
	=	-252.336	/	2068.7425
	=	-12.20 %

Renascience's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	0	/	( ( (2088.833 - 126.008)	+	(1957.093 - 57.761) )	/ 2 )
	=	0	/	( ( 1962.825	+	1899.332 )	/ 2 )
	=	0	/	1931.0785
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Renascience (TSE:4889) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Renascience ROCE % Related Terms

Thank you for viewing the detailed overview of Renascience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renascience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023

Website

https://www.renascience.co.jp

Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines